symmetric dimethylarginine has been researched along with Pneumonia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernasconi, L; Christ-Crain, M; Henzen, C; Hoess, C; Huber, A; Kulkarni, P; Meier, MA; Mueller, B; Ottiger, M; Schuetz, P; Steuer, C; Thomann, R; Vögeli, A; Zimmerli, W | 1 |
1 other study(ies) available for symmetric dimethylarginine and Pneumonia
Article | Year |
---|---|
Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
Topics: Adult; Aged; Arginine; Biomarkers; Community-Acquired Infections; Female; Humans; Longitudinal Studies; Male; Middle Aged; Patient Admission; Pneumonia; Prevalence; Proportional Hazards Models; Risk Assessment; Risk Factors; Survival Analysis; Switzerland | 2017 |